About Dreem
Dreem is a company based in Paris (France) founded in 2014 by Quentin Soulet De Brugiere was acquired by Beacon Biosignals in July 2023. Dreem has raised $44 million across 4 funding rounds from investors including Maif, Bpifrance and Beacon Biosignals. Dreem offers products and services including Video Consultations and Home Sleep Test. Dreem operates in a competitive market with competitors including Compumedics, Holi, Somno-Art, URGONight and Morphée, among others.
- Headquarter Paris, France
- Founders Quentin Soulet De Brugiere
-
Sectors
RetailTechnology Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$44 M (USD)
in 4 rounds
-
Latest Funding Round
$35 M (USD), Series B
Jun 26, 2018
-
Investors
Maif
& 5 more
-
Employee Count
Not available
-
Acquired by
Beacon Biosignals
(Jul 11, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dreem
Dreem offers a comprehensive portfolio of products and services, including Video Consultations and Home Sleep Test.
Virtual sessions with sleep specialists for symptom evaluation and advice.
Device for accurate sleep monitoring and diagnosis in home environments.
People of Dreem
Unlock access to complete
Unlock access to complete
Funding Insights of Dreem
Dreem has successfully raised a total of $44M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $35 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Dreem
Dreem has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Maif, Bpifrance and Beacon Biosignals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Locked | Locked | Locked | |
|
Corporate backed venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Corporate consultancy, advisory, and funding services are provided to businesses.
|
Locked | Locked | Locked |
Investor details for Dreem
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dreem
Investment portfolio details for Dreem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dreem
Detailed financials for Dreem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dreem Comparisons
Peer comparison for Dreem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dreem
Dreem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Compumedics, Holi, Somno-Art, URGONight and Morphée, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Computer-aided diagnostics for sleep disorders, neurophysiology, and cardiology are developed.
|
|
| Locked | Locked | Locked |
Connected devices are offered for sleep monitoring and management.
|
|
| Locked | Locked | Locked |
An ambulatory wearable device for sleep phase analysis is developed.
|
|
| Locked | Locked | Locked |
Develops innovative EEG headband technology to enhance sleep quality.
|
|
| Locked | Locked | Locked |
An audio-based device for sleep management is offered by Morphée.
|
Detailed competitors of Dreem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dreem
Complete news archive for Dreem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dreem
Dreem was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Dreem is headquartered in Paris, France.
Dreem is a funded company, having raised a total of $44M across 4 funding rounds to date.
Dreem was founded in 2014 in Paris, France, within the wearable health technology sector. A platform is offered featuring the Dreem2 device, which incorporates an EEG sensor to track brain activity during sleep. User data is analyzed and displayed through an integrated mobile application. Non-invasive audio stimulation is employed by the device to promote extended periods of deep sleep. Operations focus on sleep monitoring and enhancement for individual users.
Dreem's top competitors include Compumedics, Holi and Somno-Art.
Dreem offers Video Consultations and Home Sleep Test.
Dreem has 6 investors. Key investors include Maif, Bpifrance, Beacon Biosignals, Johnson & Johnson Innovation – JJDC, and MAIF Avenir.